VERONIKA HETENIAK: Open Payments
NPI 1629645635 · NORTH HOLLYWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,440 in 107 payments from 18 companies in 2025. Trend: 2023 $2,138 · 2024 $2,546 · 2025 $2,440
Food & beverage: $2,175Education: $265
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $505 |
| ABBVIE INC. | 26 | $381 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $253 |
| LEO Pharma Inc. | 10 | $185 |
| PFIZER INC. | 14 | $177 |
| Amgen Inc. | 11 | $171 |
| UCB, Inc. | 3 | $157 |
| Novartis Pharmaceuticals Corporation | 5 | $116 |
| Incyte Corporation | 4 | $109 |
| GENZYME CORPORATION | 2 | $93 |
Products named: TREMFYA, SKYRIZI, CIBINQO, OTEZLA, Bimzelx, ADBRY, DUPIXENT, OPZELURA.
Industry payments across CA — which companies pay providers there.
